The keywords highlight the need for novel variants of synthases and polymerases to produce specific amino acids and dipeptides. This indicates that existing wild-type metabolic pathways suffer from rate-limiting steps or low conversion efficiency.

Low metabolic flux and intracellular accumulation of amino acids limit production efficiency. Enhancing transport and enzymatic throughput overcomes feedback inhibition and slow secretion rates.

The cluster addresses the metabolic and transport limitations that prevent high-titer production of L-glutamic acid. Overcoming these bottlenecks increases the efficiency and commercial viability of microbial fermentation.